-
January 13, 2025 Lupin Launches Minzoya TM (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets) in the United States
-
January 9, 2025 Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Oral Granules
-
January 9, 2025 Lupin Receives Tentative Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel
-
January 8, 2025 Lupin Receives EIR from U.S. FDA for its Pithampur Unit-1 Facility with VAI Classification
-
January 6, 2025 Lupin and Slurrp Successfully Conclude Lupin Aptivate Achchi Bhookh Quiz
-
December 30, 2024 Lupin Acquires Huminsulin from Lilly to Enhance Diabetes Portfolio
-
December 18, 2024 Lupin Receives Approval from U.S. FDA for Emtricitabine and Tenofovir Alafenamide Tablets
-
December 16, 2024 Lupin Digital Health Partners with Medicover Hospitals for Comprehensive Post-Discharge Cardiac Care
-
December 13, 2024 Lupin Acquires 3 Trademarks from Boehringer Ingelheim to Strengthen Diabetes Portfolio
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications